La crise actuelle rappelle à l’Europe (et sans doute à l’Amérique du Nord) les limites de la délocalisation de la production. C’est le cas pour de nombreux produits, incluant bon nombre d’ingrédients pharmaceutiques actifs (API) et de médicaments en général. Cela ouvre la possibilité...
The current crisis has highlighted the dependence of European and, indeed, North American countries on delocalised production. This is the case for many goods, including APIs and drugs in general. The opportunity is now there for European CDMOs to win additional business, but effort and adaptation...
ABOUT YPSO-FACTO Ypso-Facto is a company helping industrial firms to develop, optimize and secure their chemical and bio-processes. We commit to keeping our interests aligned with the ones of our customers. For this reason, we remain deliberately free from industrial property rights, production...
Marc-Olivier Simon and Moïse Bitton discuss the needs of CDMOs in terms of digitalization of their activities and the tools available on the market (ELN, LIMS, LES, SDMS, KM, QMS, MES etc.). While (Big) Pharmas have embraced digitalization, CDMOs seem far behind. The author see this as the result...
New user-friendly solutions help chemical processors tackle tasks beyond design and optimization Initially, steady-state simulation was used in the chemical process industries (CPI) to design a plant or a process. Advances in the technology, along with the need to produce more product in a more...
Life sciences industries still use outdated tools and methodologies to develop, optimise and operate their (bio)molecule production processes. Ypso-Facto proposes to take a fresh look at the needs and expectations of this sector. Read the full article in the last edition of Speciality Chemicals...
"By adopting chemical engineering good practices earlier in process development, a major step forward would be taken" Read the full panel discussion in Chemistry Today , vol. 36 (3), 2018, pp 26-34
Nowadays process development is generally experiment-based with a traditional trial-and-error approach, direct scale-up and simple use of statistical tools. We are convinced that the fine chemical and biochemical industries will evolve towards more digitally designed processes based on fundamental...
Créée en 2014, Ypso-Facto aide les industriels de la chimie et des biotechnologies à développer, sécuriser et optimiser leurs procédés. Elle s’appuie sur une équipe disposant d’une forte expérience à la fois industrielle et universitaire pour proposer de manière objective et rigoureuse...
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.